CSNK1A1 and breast cancer: In addition to the obvious effects dysfunctional CK1 activity would have on p53-dependent genomic stability as discussed above, CK1ɛ mutations in breast cancer were found to cause loss-of-function in the canonical Wnt signalling pathway [131].